» Articles » PMID: 3531296

Agitated Behaviors in the Elderly. I. A Conceptual Review

Overview
Specialty Geriatrics
Date 1986 Oct 1
PMID 3531296
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Agitation is a significant problem for the elderly, their families, and their caretakers. Although much of the literature on agitation is pharmacologic in nature, several papers demonstrate demographic and environmental approaches to the problem. The literature review accentuates the gaps in both assessment and knowledge of the phenomenon. A conceptual framework and a rigorous methodology need to be developed for studying agitation. On these bases, research could explore the manifestations of agitation and the frequency of occurrence, predisposing factors for agitation, precipitating factors which trigger agitation, consequences of agitation for the elderly and for their caretakers, and the efficacy of alternative interventions. This paper proposes a definition of agitation and develops an initial conceptual framework in which to examine it.

Citing Articles

Music-based therapeutic interventions for people with dementia.

van der Steen J, van der Wouden J, Methley A, Smaling H, Vink A, Bruinsma M Cochrane Database Syst Rev. 2025; 3:CD003477.

PMID: 40049590 PMC: 11884930. DOI: 10.1002/14651858.CD003477.pub5.


Incidence and factors associated with agitation in patients on mechanical ventilators in Amhara Region, North-West Ethiopia: a multi-center study.

Asmare T, Tawuye H, Tegegne B, Admass B Sci Rep. 2025; 15(1):5958.

PMID: 39966461 PMC: 11836337. DOI: 10.1038/s41598-025-90148-3.


Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol.

Lapid M, Merrill J, Mueller M, Hermida A, Nykamp L, Andrus J PLoS One. 2024; 19(6):e0303894.

PMID: 38941338 PMC: 11213353. DOI: 10.1371/journal.pone.0303894.


The effects of individual music therapy in nursing home residents with dementia to improve general well-being: study protocol of a randomized controlled trial.

Baroni Caramel V, van der Steen J, Vink A, Janus S, Twisk J, Scherder E BMC Geriatr. 2024; 24(1):290.

PMID: 38539079 PMC: 10976838. DOI: 10.1186/s12877-024-04863-z.


A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.

Banerjee S, Farina N, Henderson C, High J, Stirling S, Shepstone L Health Technol Assess. 2023; 27(23):1-108.

PMID: 37929672 PMC: 10641860. DOI: 10.3310/VPDT7105.